The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 11, 2007
Filed:
Sep. 21, 2005
Jia Liu, San Diego, CA (US);
Naresh Nayyar, San Diego, CA (US);
Ming Guo, San Diego, CA (US);
Zhen-ping Wu, La Jolla, CA (US);
Bennett Chaplin Borer, San Diego, CA (US);
Aparna Nadig Srirangam, San Diego, CA (US);
Mark Bryan Mitchell, San Diego, CA (US);
Yi LI, San Diego, CA (US);
Jan-jon Chu, Carlsbad, CA (US);
Jia Liu, San Diego, CA (US);
Naresh Nayyar, San Diego, CA (US);
Ming Guo, San Diego, CA (US);
Zhen-Ping Wu, La Jolla, CA (US);
Bennett Chaplin Borer, San Diego, CA (US);
Aparna Nadig Srirangam, San Diego, CA (US);
Mark Bryan Mitchell, San Diego, CA (US);
Yi Li, San Diego, CA (US);
Jan-Jon Chu, Carlsbad, CA (US);
Agouron Pharmaceuticals, Inc., San Diego, CA (US);
Cancer Research Technology Ltd., London, GB;
Abstract
The present invention relates to novel polymorphic and amorphous forms of a phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one, and to processes for their preparation. Such polymorphic forms may be a component of a pharmaceutical composition and may be used to treat a mammalian disease condition mediated by poly(ADP-ribose) polymerase activity including the disease condition such as cancer.